| 試験進捗状況 | 一般募集中/Open public recruiting |
| UMIN試験ID | UMIN000044017 |
| 受付番号 | R000050266 |
| 科学的試験名 | 腸内環境が同種造血幹細胞移植時の腸管移植片対宿主病発症に与える影響の解明 |
| 一般公開日(本登録希望日) | 2021/04/30 |
| 最終更新日 | 2021/11/24 (2版) |
| 基本情報/Basic information | |||
| 一般向け試験名/Public title | 腸内環境が造血幹細胞移植時の合併症である腸管移植片対宿主病発症に与える影響の解明 | Impact of gut environment on the development of intestinal graft-versus-host disease, a complication of hematopoietic stem cell transplantation | |
| 一般向け試験名略称/Acronym | 腸内環境が造血幹細胞移植時の合併症である腸管移植片対宿主病発症に与える影響の解明 | Impact of gut environment on the development of intestinal graft-versus-host disease, a complication of hematopoietic stem cell transplantation | |
| 科学的試験名/Scientific Title | 腸内環境が同種造血幹細胞移植時の腸管移植片対宿主病発症に与える影響の解明 | Impact of gut environment on the development of intestinal graft-versus-host disease during allogeneic hematopoietic stem cell transplantation | |
| 科学的試験名略称/Scientific Title:Acronym | 腸内環境が同種造血幹細胞移植時の腸管移植片対宿主病発症に与える影響の解明 | Impact of gut environment on the development of intestinal graft-versus-host disease during allogeneic hematopoietic stem cell transplantation | |
| 試験実施地域/Region |
|
||
| 対象疾患/Condition | ||||
| 対象疾患名/Condition | 同種造血幹細胞移植が適応となる血液疾患 | Hematological disorders eligible for allogeneic hematopoietic stem cell transplantation | ||
| 疾患区分1/Classification by specialty |
|
|||
| 疾患区分2/Classification by malignancy | 悪性腫瘍/Malignancy | |||
| ゲノム情報の取扱い/Genomic information | いいえ/NO | |||
| 目的/Objectives | ||
| 目的1/Narrative objectives1 | 腸管GVHD発症に関わる腸内環境を解析し、発症予測マーカーや腸管GVHDの病態制御に寄与する新規標的を同定する。 | To investigate the gut environment involved in the pathogenesis of intestinal GVHD and to identify predictive markers and novel targets that contribute to the modulation of intestinal GVHD pathogenesis. |
| 目的2/Basic objectives2 | その他/Others | |
| 目的2 -その他詳細/Basic objectives -Others | 病態解明 | Unraveling disease pathophysiology |
| 試験の性質1/Trial characteristics_1 | 探索的/Exploratory | |
| 試験の性質2/Trial characteristics_2 | 実務的/Pragmatic | |
| 試験のフェーズ/Developmental phase | 該当せず/Not applicable | |
| 評価/Assessment | ||
| 主要アウトカム評価項目/Primary outcomes | 腸管GVHD発症に関与する腸内環境 | Gut environment involved in the onset of intestinal GVHD |
| 副次アウトカム評価項目/Key secondary outcomes | 腸管GVHDの重症度に関与する腸内環境
GVHD以外の合併症を含めた移植後の予後に関与する腸内環境 患者とドナーの腸内環境の類似性とGVHDの病態・予後との関連性 自己造血からドナー造血に至る過程における腸内環境の変化 腸管GVHDと炎症性腸疾患の腸内環境の比較 腸管GVHDの内視鏡所見と重症度との関連性 |
The gut environment involved in the severity of intestinal GVHD
Intestinal environment involved in prognosis after transplantation Similarity of gut environment between patients and donors and its relation to pathogenesis and prognosis of GVHD Alterations in the gut environment during the process from autologous to donor hematopoiesis Comparison of the gut environment in intestinal GVHD and inflammatory bowel disease Relationship between endoscopic findings and severity of intestinal GVHD |
| 基本事項/Base | ||
| 試験の種類/Study type | 観察/Observational | |
| 試験デザイン/Study design | ||
| 基本デザイン/Basic design | ||
| ランダム化/Randomization | ||
| ランダム化の単位/Randomization unit | ||
| ブラインド化/Blinding | ||
| コントロール/Control | ||
| 層別化/Stratification | ||
| 動的割付/Dynamic allocation | ||
| 試験実施施設の考慮/Institution consideration | ||
| ブロック化/Blocking | ||
| 割付コードを知る方法/Concealment | ||
| 介入/Intervention | ||
| 群数/No. of arms | ||
| 介入の目的/Purpose of intervention | ||
| 介入の種類/Type of intervention | ||
| 介入1/Interventions/Control_1 | ||
| 介入2/Interventions/Control_2 | ||
| 介入3/Interventions/Control_3 | ||
| 介入4/Interventions/Control_4 | ||
| 介入5/Interventions/Control_5 | ||
| 介入6/Interventions/Control_6 | ||
| 介入7/Interventions/Control_7 | ||
| 介入8/Interventions/Control_8 | ||
| 介入9/Interventions/Control_9 | ||
| 介入10/Interventions/Control_10 | ||
| 適格性/Eligibility | |||||
| 年齢(下限)/Age-lower limit |
|
||||
| 年齢(上限)/Age-upper limit |
|
||||
| 性別/Gender | 男女両方/Male and Female | ||||
| 選択基準/Key inclusion criteria | 山形大学医学部附属病院にて同種造血幹細胞移植を受ける患者およびそのドナー
倫理審査委員会にて承認を得た同意説明文書にて、研究の目的等の十分な説明を受け、本人の自由意志による文書同意が得られた患者およびそのドナー 同意取得時の年齢が20歳以上の患者およびそのドナー |
Patients and their donors undergoing allogeneic hematopoietic stem cell transplantation at Yamagata University Hospital
Patients and their donors who have been fully informed of the purpose of the study in the consent document approved by the Ethical Review Committee and have given their free written consent. Patients and their donors who are 20 years of age or older at the time of consent. |
|||
| 除外基準/Key exclusion criteria | 同時性の重複癌がある患者
人工肛門造設を含む腸管切除歴のある患者 採便ができない患者。ただし、ドナーのみ採便ができず患者は採便が可能な場合には、患者は除外しない。 その他、研究者が不適当とみなした者 |
Patients with synchronous multiple cancers.
Patients with a history of bowel resection. Patients who are unable to collect stool. However, if only the donor is unable to collect stool and the patient is able to collect stool, the patient will not be excluded. Other patients deemed inappropriate by the investigators. |
|||
| 目標参加者数/Target sample size | 160 | ||||
| 責任研究者/Research contact person | ||||||||||||||
| 責任研究者/Name of lead principal investigator |
|
|
||||||||||||
| 所属組織/Organization | 山形大学医学部 | Faculty of Medicine, Yamagata University | ||||||||||||
| 所属部署/Division name | 内科学第二講座 | Department of Gastroenterology | ||||||||||||
| 郵便番号/Zip code | 990-9585 | |||||||||||||
| 住所/Address | 山形市飯田西2-2-2 | 2-2-2 Iida-Nishi, Yamagata, Japan | ||||||||||||
| 電話/TEL | 0236285309 | |||||||||||||
| Email/Email | y-ueno@med.id.yamagata-u.ac.jp | |||||||||||||
| 試験問い合わせ窓口/Public contact | ||||||||||||||
| 試験問い合わせ窓口担当者/Name of contact person |
|
|
||||||||||||
| 組織名/Organization | 山形大学医学部 | Faculty of Medicine, Yamagata University | ||||||||||||
| 部署名/Division name | 内科学第二講座 | Department of Gastroenterology | ||||||||||||
| 郵便番号/Zip code | 9909585 | |||||||||||||
| 住所/Address | 飯田西2-2-2 | 2-2-2 Iida-Nishi, Yamagata, Japan | ||||||||||||
| 電話/TEL | 0236285309 | |||||||||||||
| 試験のホームページURL/Homepage URL | ||||||||||||||
| Email/Email | y-sasaki@med.id.yamagata-u.ac.jp | |||||||||||||
| 実施責任組織/Sponsor | ||
| 機関名/Institute | 山形大学 | Faculty of Medicine, Yamagata University |
| 機関名/Institute (機関選択不可の場合) |
||
| 部署名/Department | 医学部 | |
| 研究費提供組織/Funding Source | ||
| 機関名/Organization | 無し | None |
| 機関名/Organization (機関選択不可の場合) |
||
| 組織名/Division | ||
| 組織の区分/Category of Funding Organization | 自己調達/Self funding | |
| 研究費拠出国/Nationality of Funding Organization | ||
| その他の関連組織/Other related organizations | ||
| 共同実施組織/Co-sponsor | ||
| その他の研究費提供組織/Name of secondary funder(s) | ||
| IRB等連絡先(公開)/IRB Contact (For public release) | ||
| 組織名/Organization | 山形大学飯田キャンパス事務部研究支援課 | Research Support Division, Administrative Department, Yamagata University Iida Campus |
| 住所/Address | 山形市飯田西2-2-2 | 2-2-2 Iida-Nishi, Yamagata, Japan |
| 電話/Tel | 023-628-5047 | |
| Email/Email | ikekenkyu@jm.kj.yamagata-u.ac.jp | |
| 他機関から発行された試験ID/Secondary IDs | ||
| 他機関から発行された試験ID/Secondary IDs | いいえ/NO | |
| 試験ID1/Study ID_1 | ||
| ID発行機関1/Org. issuing International ID_1 | ||
| 試験ID2/Study ID_2 | ||
| ID発行機関2/Org. issuing International ID_2 | ||
| 治験届/IND to MHLW | ||
| 試験実施施設/Institutions | ||
| 試験実施施設名称/Institutions | 山形大学医学部附属病院/Yamagata University Hospital | |
| その他の管理情報/Other administrative information | ||||||||
| 一般公開日(本登録希望日)/Date of disclosure of the study information |
|
|||||||
| 関連情報/Related information | ||
| プロトコル掲載URL/URL releasing protocol | ||
| 試験結果の公開状況/Publication of results | 未公表/Unpublished | |
| 結果/Result | ||
| 結果掲載URL/URL related to results and publications | ||
| 組み入れ参加者数/Number of participants that the trial has enrolled | ||
| 主な結果/Results | ||
| 主な結果入力日/Results date posted | ||
| 結果掲載遅延/Results Delayed | ||
| 結果遅延理由/Results Delay Reason | ||
| 最初の試験結果の出版日/Date of the first journal publication of results | ||
| 参加者背景/Baseline Characteristics | ||
| 参加者の流れ/Participant flow | ||
| 有害事象/Adverse events | ||
| 評価項目/Outcome measures | ||
| 個別症例データ共有計画/Plan to share IPD | ||
| 個別症例データ共有計画の詳細/IPD sharing Plan description | ||
| 試験進捗状況/Progress | ||||||||
| 試験進捗状況/Recruitment status | 一般募集中/Open public recruiting | |||||||
| プロトコル確定日/Date of protocol fixation |
|
|||||||
| 倫理委員会による承認日/Date of IRB |
|
|||||||
| 登録・組入れ開始(予定)日/Anticipated trial start date |
|
|||||||
| フォロー終了(予定)日/Last follow-up date |
|
|||||||
| 入力終了(予定)日/Date of closure to data entry | ||||||||
| データ固定(予定)日/Date trial data considered complete | ||||||||
| 解析終了(予定)日/Date analysis concluded | ||||||||
| その他/Other | ||
| その他関連情報/Other related information | 前向き観察研究
2021年5月1日~2026年3月31日までに山形大学医学部附属病院第三内科(血液内科)で同種造血幹細胞移植を行う20歳以上の患者およびそのドナー。移植に至った適応疾患は問わない。移植前およびドナー由来造血生着までの間の臨床所見、血液所見、内視鏡所見、腸内細菌叢、腸内メタボロームをGVHD発症群と非発症群で比較する。またドナーとレシピエントの腸内環境を比較する。 |
Prospective observational study
The patients and their donors aged 20 years or older who will undergo allogeneic hematopoietic stem cell transplantation at Yamagata University Hospital between May 1, 2021 and March 31, 2026. Any indication that led to the transplant is eligible. The clinical, hematological, and endoscopic findings, gut microbiota, and gut metabolome will be compared between the GVHD group and the non-GVHD group before transplantation and throughout the period of donor-derived hematopoietic engraftment. We will also compare the gut environments of donors and recipients. |
| 管理情報/Management information | ||||||||
| 登録日時/Registered date |
|
|||||||
| 最終更新日/Last modified on |
|
|||||||
| 閲覧ページへのリンク/Link to view the page | |
| URL(日本語) | https://upload.umin.ac.jp/cgi-open-bin/ctr/ctr_view.cgi?recptno=R000050266 |
| URL(英語) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000050266 |